FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Trude Giverhaug

Research Profile

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Beate Hennie Garcia; Lars Småbrekke; Thor Trovik; Trude Giverhaug
Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.
Guttorm Raknes; Trude Giverhaug
[Low dosage naltrexone].
Guttorm Raknes; Trude Giverhaug
[Naltrexone--high expectations to low dosages].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Trude Giverhaug (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Beate Hennie Garcia; Lars Småbrekke; Thor Trovik; Trude Giverhaug
Application of the MAT-CHDSP to assess guideline adherence and therapy goal achievement in secondary prevention of coronary heart disease after percutaneous coronary intervention.
European journal of clinical pharmacology 2013;69(3):703-9.
2011: Guttorm Raknes; Trude Giverhaug
[Low dosage naltrexone].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2011;131(15):1415-6.
2011: Guttorm Raknes; Trude Giverhaug
[Naltrexone--high expectations to low dosages].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2011;131(8):844-6.
2011: Beate Hennie Garcia; June Utnes; Liv Unni Naalsund; Trude Giverhaug
MAT-CHDSP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease.
Pharmacoepidemiology and drug safety 2011;20(3):249-57.
2009: Gro Dahlseng Håkonsen; Merethe Harjo Pettersen; Svetlana Skurtveit; Trude Giverhaug
[Concomitant use of warfarin, analgesics and anti-inflammatory agents].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2009;129(12):1217-20.
2005: Trude Giverhaug; Christine Bruland; Thor Trovik
Secondary prevention in coronary heart disease: goal achievement and drug prescribing.
Pharmacy world & science : PWS 2005;27(6):472-4.
2004: Trude Giverhaug; A Falck; Bjørn O Eriksen
Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
Journal of human hypertension 2004;18(9):649-54.
2002: Thrina Loennechen; Roy Andre Lysaa; Trude Giverhaug; Ingebrigt Sylte; Lars-Eirik Mathiesen; Jarle Aarbakke
[New techniques for optimization of thiopurine therapy in leukemia and transplantation].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2002;122(11):1107-10.
1999: Trude Giverhaug; Thrina Loennechen; Jarle Aarbakke
The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX).
General pharmacology 1999;33(4):341-6.
1998: Trude Giverhaug; Thrina Loennechen; Jarle Aarbakke
Increased concentrations of methylated 6-mercaptopurine metabolites and 6-thioguanine nucleotides in human leukemic cells in vitro by methotrexate.
Biochemical pharmacology 1998;55(10):1641-6.
1997: Trude Giverhaug; Stein Bergan; Thrina Loennechen; Hans Erik Rugstad; Jarle Aarbakke
Analysis of methylated 6-mercaptopurine metabolites in human red blood cells: comparison of two methods.
Therapeutic drug monitoring 1997;19(6):663-8.
1997: Stein Bergan; Hans Erik Rugstad; B Klemetsdal; Trude Giverhaug; OH Bentdal; G Sødal; Anders Hartmann; Jarle Aarbakke; Oddvar Stokke
Possibilities for therapeutic drug monitoring of azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells.
Therapeutic drug monitoring 1997;19(3):318-26.
1997: Trude Giverhaug; O M Fuskevaag; Jarle Aarbakke
Methotrexate increases red blood cell concentrations of 6-methylmercaptopurine ribonucleotide in rats in vivo.
Cancer chemotherapy and pharmacology 1997;40(4):367-70.
1996: R A Lysaa; Trude Giverhaug; H L Wold; Jarle Aarbakke
Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide.
European journal of clinical pharmacology 1996;49(5):393-6.
1996: Trude Giverhaug; B Klemetsdal; R Lysaa; Jarle Aarbakke
Intraindividual variability in red blood cell thiopurine methyltransferase activity.
European journal of clinical pharmacology 1996;50(3):217-20.
1995: B Klemetsdal; B Straume; R Lysaa; Trude Giverhaug; Jarle Aarbakke
Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity.
European journal of clinical pharmacology 1995;48(6):495-9.
1994: B Klemetsdal; B Straume; Trude Giverhaug; Jarle Aarbakke
Low catechol-O-methyltransferase activity in a Saami population.
European journal of clinical pharmacology 1994;46(3):231-5.

FIND

DISCOVER

PROMOTE

Trude Giverhaug

Research Profile

Chemicals & Drugs

Anatomy

Geographic Areas

Concepts & Ideas

Phenomena

Procedures

Activities & Behaviors

Disorders